UBRELVY 100 mg/1

UBRELVY 100 mg tablets contain ubrogepant, a medication used for acute migraine treatment. This oral tablet is designed to provide relief from migraine headaches. Ubrogepant is a CGRP receptor antagonist, a class of drugs that targets specific receptors involved in migraine pain.

UBRELVY 100 mg tablets are primarily used for the acute treatment of migraine headaches with or without aura in adults. Ubrogepant works by blocking the activity of calcitonin gene-related peptide (CGRP) receptors, which are involved in the onset of migraine attacks. This medication is not intended for preventive use but rather for the relief of migraine symptoms once they begin.

Common effects of Ubrevly 100 mg tablets may include nausea, somnolence, and dry mouth. Some users might experience fatigue or dizziness. These effects are generally mild and temporary, but if they persist or worsen, it is advisable to consult a healthcare provider.

UBRELVY 100 mg tablets should be used with caution in individuals with liver impairment. It is important to follow the prescribed dosage and administration instructions. This medication should not be used for the prevention of migraines but rather for the treatment of acute migraine attacks.

UBRELVY 100 mg tablets may interact with other medications, including strong CYP3A4 inhibitors and inducers. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol should be avoided while using this medication.